

Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure
Oct 10, 2023
Dr Emily Atkins from The George Institute in Sydney discusses the cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure. They explore potential benefits, trial results, economic evaluation, patient tolerance, and future research on combination pills.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Cost-Effectiveness of Ultra-Low-Dose Quadruple Combination Therapy for High Blood Pressure
01:46 • 5min
Economic Evaluation of Quartet Trial
06:34 • 5min
Patient Tolerance and Generalizability of Quad Pill and Cost-Effectiveness Results
11:13 • 2min
Further Research and Accessibility of Combination Pills for Blood Pressure Control
13:24 • 5min